Faze Three Ltd vs Skybiotech Healthcare Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jul 03, 2026

Key Highlights

The Latest Trading Price of Faze Three Ltd is ₹ 624.35 as of 02 Jul 15:30 . The P/E Ratio of Faze Three Ltd changed from 20.7 on March 2025 to 18.6 on March 2024 . This represents a CAGR of -2.12% over 5 yearsThe P/E Ratio of Skybiotech Healthcare Limited changed from 0 on March 2025 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years The Market Cap of Faze Three Ltd changed from ₹ 841.92 crore on March 2025 to ₹ 866.97 crore on March 2024 . This represents a CAGR of 0.59% over 5 yearsThe Market Cap of Skybiotech Healthcare Limited changed from ₹ 31.33 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 years The revenue of Faze Three Ltd for the Mar '26 is ₹ 280.35 crore as compare to the Dec '25 revenue of ₹ 229.33 crore. This represent the growth of 22.25% The revenue of Skybiotech Healthcare Limited for the Mar '26 is ₹ 1.98 crore as compare to the Dec '25 revenue of ₹ 1.04 crore. This represent the growth of 90.38% The ebitda of Faze Three Ltd for the Mar '26 is ₹ 37.16 crore as compare to the Dec '25 ebitda of ₹ 20.98 crore. This represent the growth of 77.12% The ebitda of Skybiotech Healthcare Limited for the Mar '26 is ₹ -0.73 crore as compare to the Dec '25 ebitda of ₹ -0.36 crore. This represent the growth of 102.78% The net profit of Faze Three Ltd changed from ₹ 7.26 crore to ₹ 19.6 crore over 8 quarters. This represents a CAGR of 64.31% The net profit of Skybiotech Healthcare Limited changed from ₹ 0.25 crore to ₹ -0.3 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Faze Three Ltd changed from 2.12 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Skybiotech Healthcare Limited changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Faze Three Ltd

Faze Three Limited was initially incorporated as a private Company in the name of 'Faze Three Exports Private Limited' in January, 1985.
The Company was converted into a public limited Company and the name of the Company was changed to Faze Three Exports Limited in January, 1994 and again to Faze Three Limited in 2003.
Company is engaged in manufacturing and export of superior quality high-end Home Textile products items viz. bathmats, rugs, blankets, throws, cushions, etc..
The Company is a direct exporter to top retail store chains in USA, UK and Europe. Apart from these, it has a diversified product basket which includes cotton and rubber backed bathmats, durries, tufted bed spreads and throws, hand tufted carpets and rugs made of cotton and wool, cushion covers, curtains as well as poly cotton and cotton damask table covers, napkins amongst many others.

About Skybiotech Healthcare Limited

Skybiotech Healthcare Limited was initially incorporated as Kapil Cotex Limited on October 14, 1983.
The Company has altered a change in name with due approval from the Registrar of Companies to Skybiotech Healthcare Limited in 2025. he Company is involved in Spinning, weaving and finishing of textiles. During the concerned year, it did not get any revenue from its main objects.
However, it gives consultancy & assistance in selling the goods of foreign clients & earned brokerage/consultancy income.
It also deals in shares & Securities, where it earned capital gains & dividend income. Company has acquired 72.52% stake in M/s.
Skybiotech Lifescience Private Limited, making it a subsidiary of the Company in 2024.

FAQs for the comparison of Faze Three Ltd and Skybiotech Healthcare Limited

Which company has a larger market capitalization, Faze Three Ltd or Skybiotech Healthcare Limited?

Market cap of Faze Three Ltd is 1,518 Cr while Market cap of Skybiotech Healthcare Limited is 36 Cr

What are the key factors driving the stock performance of Faze Three Ltd and Skybiotech Healthcare Limited?

The stock performance of Faze Three Ltd and Skybiotech Healthcare Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Faze Three Ltd and Skybiotech Healthcare Limited?

As of July 3, 2026, the Faze Three Ltd stock price is INR ₹624.35. On the other hand, Skybiotech Healthcare Limited stock price is INR ₹191.85.

How do dividend payouts of Faze Three Ltd and Skybiotech Healthcare Limited compare?

To compare the dividend payouts of Faze Three Ltd and Skybiotech Healthcare Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.